Cargando…
Understanding nontuberculous mycobacterial lung disease: it’s been a long time coming
With a surprising predictability, most studies and reviews addressing therapy for nontuberculous mycobacterial (NTM) lung disease either start or end by mentioning the paucity of data from randomized and controlled trials. That is a legitimate criticism for NTM lung disease therapy, but it also some...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000Research
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133682/ https://www.ncbi.nlm.nih.gov/pubmed/27990278 http://dx.doi.org/10.12688/f1000research.9272.1 |